cetylpyridinium chloride anhydrous has been researched along with Paraproteinemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alyea, EP; Bellucci, R; Gallagher, M; Gershwin, ME; Li, S; Munshi, NC; Oertelt, S; Porcheray, F; Ritz, J; Soiffer, RJ; Weller, E; Zorn, E | 1 |
| Barlogie, B; Chen, LC; Crowley, J; Dhodapkar, MV; Durie, B; Gure, AO; Jagannath, S; Kukreja, A; Matthews, P; Mazumder, A; Ritter, G; Scanlan, MJ; Shaughnessy, JD; Simpson, AJ; Spisek, R; Vesole, D; Zebroski, HA | 1 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Paraproteinemias
| Article | Year |
|---|---|
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.
Topics: Aged; Antibodies; Cell Line, Tumor; Dihydrolipoyllysine-Residue Acetyltransferase; Epitope Mapping; Female; Health; Hematopoietic Stem Cell Transplantation; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondrial Proteins; Paraproteinemias; Transplantation, Homologous | 2007 |
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy.
Topics: Biomarkers; Cell Proliferation; Cells, Cultured; Disease Progression; Embryonic Stem Cells; Health; HMGB Proteins; Humans; Immunoglobulin G; Multiple Myeloma; Neoplasms; Paraproteinemias; SOXB1 Transcription Factors; T-Lymphocytes; Transcription Factors; Treatment Outcome | 2007 |